Recognized standard
F2024-10 (Reapproved 2016)
FDA recognition 8-195 · ASTM · Materials
Key facts
| Recognition number | 8-195 |
|---|---|
| Designation | F2024-10 (Reapproved 2016) |
| Title | Standard Practice for X-Ray Diffraction Determination of Phase Content of Plasma-Sprayed Hydroxyapatite Coatings |
| Standards developer | ASTM International |
| Specialty area | Materials |
| Date of entry | Aug 21, 2017 |
| Device classes | Class 2, Class 3 |
| Scope (excerpt) | 1.1 This practice is for the determination, by the Reference Intensity Ratio External Standard Method, of the percent by weight of the crystalline phases, hydroxyapatite (HA), beta-(whitlockite) tricalcium phosphate (beta-TCP), and calcium oxide (CaO) in coatings deposited upon metallic substrates… |
At a glance
- 10–99 Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: